TerSera Therapeutics Patents – Insights & Stats (Updated 2023)

TerSera Therapeutics has a total of 107 patents globally, out of which 86 have been granted. Of these 107 patents, more than 84% patents are active. The United States of America is where TerSera Therapeutics has filed the maximum number of patents, followed by Germany and Canada. Parallelly, United States of America seems to be the main focused R&D centre and also is the origin country of TerSera Therapeutics.

TerSera Therapeutics was founded in 2016. TerSera Therapeutics is a company that specializes in pharmaceuticals. The company’s area of expertise is creating and purchasing specialist pharmaceutical products, with a particular emphasis on particular therapeutic areas.

Do read about some of the most popular patents of TerSera Therapeutics which have been covered by us in this article and also you can find TerSera Therapeutics patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over TerSera Therapeutics patent portfolio.

How many patents does TerSera Therapeutics have?

TerSera Therapeutics has a total of 107 patents globally. These patents belong to 17 unique patent families. Out of 107 patents, 90 patents are active.

How Many Patents did TerSera Therapeutics File Every Year?

TerSera Therapeutics Patent Filing Trend

Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.

Year of Patents Filing or GrantTerSera Therapeutics Applications FiledTerSera Therapeutics Patents Granted
20232
20224
202135
202013
201921
20184
201714
20164
201511
201417
201328
2012149
201179

Explore the top-performing drugs that dominate the Pharmaceutical Industry

Patent NumberCompanyProductBrandRevenuePatent Expiry Date
US9174975Sumitomo PharmaLurasidone HydrochlorideLatuda$1.75BJun-26
US7612199AlfasigmaRifaximinXifaxan$1.64BNov-24
US7902206AlfasigmaRifaximinXifaxan$1.64BNov-24
US8158644AlfasigmaRifaximinXifaxan$1.64BNov-24
US7371727Ironwood PharmaLinaclotideLinzess$1.00BMar-25

How many TerSera Therapeutics patents are Alive/Dead?

Worldwide Patents

TerSera Therapeutics Patent Portfolio

How Many Patents did TerSera Therapeutics File in Different Countries?

TerSera Therapeutics Worldwide Patent Filing

Countries in which TerSera Therapeutics Filed Patents

CountryPatent
United States Of America37
Germany9
Canada8
Israel7
New Zealand6
Brazil5
Austria5
Australia5
Europe5
Norway4
South Africa4
Singapore3
Italy3
Spain3
Hungary1

Where are Research Centers of TerSera Therapeutics Patents Located?

R&D Centres of TerSera Therapeutics

10 Best TerSera Therapeutics Patents

US7118552B2 is the most popular patent in the TerSera Therapeutics portfolio. It has received 179 citations so far from companies like Oracle, Safeshot Technologies, The Medical House Limited.

Below is the list of 10 most cited patents of TerSera Therapeutics:

Publication NumberCitation Count
US7118552B2179
US7500964B2108
US7220247B2102
US7524812B264
US7553840B257
US7709493B240
US7723345B224
US7268109B220
US8268774B216
US7977307B213

What are TerSera Therapeutics key innovation segments?

What Technologies are Covered by TerSera Therapeutics?

The chart below distributes patents filed by TerSera Therapeutics in different countries on the basis of the technology protected in patents. It also represents the markets where TerSera Therapeutics thinks it’s important to protect particular technology inventions.

R&D Focus: How has TerSera Therapeutics search focus changed over the years?

EXCLUSIVE INSIGHTS COMING SOON!

Interested in knowing about the areas of innovation that are being protected by TerSera Therapeutics?

Related Articles

Monetago Patents – Insights and Stats (Updated 2024)

Monetago has a total of 10 patents globally, out of which none have been granted. Of these 10 patents, all the patents are inactive. The United States of America is where Monetago has filed all their patents. Parallelly, United States of America seems to be the main focused R&D centre

Read More »

Leave a Comment

Fill the form to get the details:

Fill the form to get the details:

Our comprehensive report provides an in-depth look into the patent portfolio. The report includes a breakdown of the patent portfolio across various technologies, listing the patent along with brief summaries of each patent's technology.